Pharmaceutical formulations
First Claim
Patent Images
1. A solid orodispersible pharmaceutical dosage form comprising from 10 to 600 μ
- g desmopressin acetate, measured as the free base, which solid orodispersible dosage form disintegrates in the mouth within 10 seconds.
0 Assignments
0 Petitions
Accused Products
Abstract
Good bioavailability of desmopressin can be obtained by means of an orodispersible pharmaceutical dosage form. Preferred dosage forms comprise desmopressin and an open matrix network which is an inert water-soluble or water-dispersible carrier material. Desmopressin formulated in this way is useful for voiding postponement, or the treatment or prevention of incontinence, primary noctural enuresis (PNE), nocturia or central diabetes insipidus. Peptides other than desmopressin can also be formulated in this way.
142 Citations
9 Claims
-
1. A solid orodispersible pharmaceutical dosage form comprising from 10 to 600 μ
- g desmopressin acetate, measured as the free base, which solid orodispersible dosage form disintegrates in the mouth within 10 seconds.
- View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9)
Specification